LIVDELZI
Live / Applied — Statement of use — processing complete, to examiner (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 24 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98517068
- Mark type
- Design + words
- Filed
- 24 Apr 2024
- Published for opposition
- 17 Dec 2024
- Attorney of record
- Shelley Lai
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for treatment of inflammatory diseases and disorders; pharmaceutical preparations for treatment of fibrosis
Owner
- CymaBay Therapeutics, Inc., Foster City, CA, US
- CymaBay Therapeutics, Inc., Newark, CA, US
Prosecution history
- 14 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jul 2025 — USE AMENDMENT FILED
- 13 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 30 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 21 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Nov 2024 — EXAMINERS AMENDMENT E-MAILED